Expanding the Market Through Fear

There’s a good article in Vanity Fair about the scandal at Valeant, the pharmaceuticals maker. NPR has also covered this for those not interested in reading. http://www.vanityfair.com/news/2016/06/the-valeant-meltdown-and-wall-streets-major-drug-problem The part that has everyone up in arms has to do with their pricing strategy. The examples given are Syprine and Cuprimine, for

Continue reading »